GlassScriptPhysician profile
Geetha Ramaswamy
NPI 1841216595
$14,521.55
in general payments reported to CMS, 2019-2025
39 companies · $3,216 in 2025
The $3,216 reported for 2025 was more than what 76% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $1,659 · 2020: $1,008 · 2021: $980 · 2022: $2,592 · 2023: $3,274 · 2024: $1,793 · 2025: $3,216.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,509 · Travel and Lodging: $1,774.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,509.23 |
| Travel and Lodging | $1,774.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,410.49 | 2019-2025 | General - Balloon Catheters, Watchman Access System, Watchman Flx |
| Medtronic, INC. | $2,365.07 | 2021-2025 | Corevalve Evolut R, Azure Xt Dr Mri Surescan |
| Edwards Lifesciences Corporation | $2,257.50 | 2021-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia |
| Abbott Laboratories | $1,719.95 | 2019-2025 | Amplatzer Amulet, Jot Dx, Thoratec Heartmate 3 Lvas Implant Kit |
| Medtronic Vascular, INC. | $1,027.60 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $767.41 | 2021-2025 | Camzyos, Eliquis |
| Novartis Pharmaceuticals Corporation | $618.86 | 2019-2025 | |
| Abiomed | $559.61 | 2021-2025 | Impella |
| Pfizer INC. | $488.45 | 2019-2024 | |
| Janssen Pharmaceuticals, INC | $439.02 | 2019-2023 | Xarelto |
| Amgen INC. | $257.89 | 2019-2025 | Repatha, Repatha |
| Philips North America LLC | $208.19 | 2019-2024 | (Ck4) Mcot |
| Merck Sharp & Dohme LLC | $199.34 | 2022-2025 | Verquvo |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $146.69 | 2019-2023 | Lifevest |
| Boehringer Ingelheim Pharmaceuticals, INC. | $113.04 | 2021-2025 | Jardiance |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $98.77 | 2024 | Orsiro Mission |
| Bayer Healthcare Pharmaceuticals INC. | $93.57 | 2025 | |
| Alnylam Pharmaceuticals INC. | $86.08 | 2024-2025 | Onpattro |
| Inspire Medical Systems, INC. | $83.31 | 2023-2024 | Inspire |
| Terumo Medical Corporation | $59.58 | 2020-2023 | Glidewire, Heartrail |
| Sanofi-Aventis U.S. LLC | $58.59 | 2019-2024 | |
| Astrazeneca Pharmaceuticals LP | $50.70 | 2020-2023 | Farxiga |
| Shockwave Medical, INC | $46.43 | 2025 | |
| Bard Peripheral Vascular, INC. | $43.29 | 2023 | Venovo |
| Kiniksa Pharmaceuticals International, Plc | $42.37 | 2024 | Arcalyst |
| Teleflex LLC | $39.60 | 2023-2025 | Manta, Guideliner |
| Irhythm Technologies, INC. | $30.72 | 2019 | |
| Bardy Diagnostics, INC. | $23.53 | 2019-2021 | |
| Kiniksa Pharmaceuticals, LTD. | $22.79 | 2022 | |
| Inari Medical, INC. | $21.56 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Agepha Pharma Fz LLC | $21.47 | 2024 | Lodoco |
| Baxter Healthcare | $16.82 | 2024 | Hillrom - Carnation Ambulatory Monitor |
| Scpharmaceuticals INC. | $16.34 | 2024 | |
| Amarin Pharma, INC. | $15.84 | 2019 | |
| Cardiovascular Systems INC. | $15.40 | 2020 | |
| Heartflow, INC. | $14.67 | 2024 | |
| Chiesi USA, INC. | $13.92 | 2021 | |
| Portola Pharmaceuticals, LLC | $13.66 | 2019 | |
| Astellas Pharma US INC | $13.43 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$2,000.00 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Geetha Ramaswamy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.